LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 46.95 | 84.90 | 4924 | 4952 | 0.9942 | 0.9980 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 46.95 | 84.90 | 599 | 4952 | 0.1210 | 0.3952 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 46.95 | 84.90 | 4970 | 4952 | 1.0035 | 1.0012 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 48.65 | 84.90 | 583 | 5328 | 0.1094 | 0.3808 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 48.65 | 84.90 | 5346 | 5328 | 1.0032 | 1.0011 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 48.65 | 84.90 | 518 | 5328 | 0.0972 | 0.3537 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 48.65 | 84.90 | 5316 | 5328 | 0.9976 | 0.9992 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 50.36 | 84.90 | 666 | 5651 | 0.1179 | 0.4051 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 50.36 | 84.90 | 5674 | 5651 | 1.0041 | 1.0013 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 50.36 | 84.90 | 682 | 5651 | 0.1207 | 0.4106 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 50.36 | 84.90 | 5703 | 5651 | 1.0092 | 1.0030 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 52.06 | 84.90 | 718 | 5990 | 0.1199 | 0.4158 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 52.06 | 84.90 | 5990 | 5990 | 0.9999 | 1.0000 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 52.06 | 84.90 | 798 | 5990 | 0.1332 | 0.4403 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 52.06 | 84.90 | 5985 | 5990 | 0.9990 | 0.9997 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.77 | 84.90 | 695 | 6252 | 0.1112 | 0.4035 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.77 | 84.90 | 6291 | 6252 | 1.0061 | 1.0020 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.77 | 84.90 | 846 | 6252 | 0.1353 | 0.4487 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.77 | 84.90 | 6345 | 6252 | 1.0148 | 1.0047 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.48 | 84.90 | 694 | 6567 | 0.1057 | 0.3978 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.48 | 84.90 | 6656 | 6567 | 1.0134 | 1.0043 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.48 | 84.90 | 824 | 6567 | 0.1255 | 0.4366 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.48 | 84.90 | 6625 | 6567 | 1.0087 | 1.0028 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 57.18 | 84.90 | 658 | 6963 | 0.0945 | 0.3800 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 57.18 | 84.90 | 7018 | 6963 | 1.0078 | 1.0025 | MN20160318_Q02 | L17 |